Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations

Area of Science:

• Pulmonology
• Clinical Epidemiology
• Biostatistics

Background:

• Cystic Fibrosis (CF) registry analyses commonly assess pulmonary exacerbations (PEx) using spirometry before and after the event.
• This traditional method compares lung function recovery to a pre-PEx baseline, potentially overattributing recovery failure to PEx.

Purpose of the Study:

• To evaluate the impact of PEx on lung function recovery in CF patients.
• To introduce and validate a comparator group (birthdays) to assess PEx recovery more accurately.

Main Methods:

• Utilized 2014 CF Foundation Patient Registry data for PEx and non-PEx (birthday) events.
• Compared percent predicted forced expiratory volume in 1 second (ppFEV1) recovery rates before and after PEx versus birthdays.
• Employed simulations to assess the influence of measurement frequency on recovery outcomes.

Main Results:

• 49.6% of individuals with PEx achieved baseline ppFEV1 recovery, compared to 36.6% after birthdays.
• Individuals experiencing both PEx and birthdays showed higher recovery post-PEx (47%) than post-birthday (34%).
• Simulations indicated measurement frequency significantly impacted recovery assessment, more so than actual lung function decline.

Conclusions:

• CF PEx recovery analyses using only pre-event baselines may be prone to artifact and overestimate PEx's contribution to disease progression.
• Incorporating comparator events like birthdays provides a more robust assessment of PEx impact on lung function in CF.
• Future CF research should utilize comparative methodologies to accurately determine the role of PEx in CF lung disease progression.